000 01346 a2200361 4500
005 20250517201503.0
264 0 _c20190304
008 201903s 0 0 eng d
022 _a2152-2669
024 7 _a10.1016/j.clml.2018.01.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOllila, Thomas A
245 0 0 _aMarrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease.
_h[electronic resource]
260 _bClinical lymphoma, myeloma & leukemia
_c03 2018
300 _a204-209 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBlood Cell Count
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInduction Chemotherapy
_xmethods
650 0 4 _aLeukemia, Myeloid, Acute
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPrognosis
650 0 4 _aRetrospective Studies
650 0 4 _aTime Factors
700 1 _aOlszewski, Adam J
700 1 _aButera, James N
700 1 _aQuesenberry, Matthew I
700 1 _aQuesenberry, Peter J
700 1 _aReagan, John L
773 0 _tClinical lymphoma, myeloma & leukemia
_gvol. 18
_gno. 3
_gp. 204-209
856 4 0 _uhttps://doi.org/10.1016/j.clml.2018.01.007
_zAvailable from publisher's website
999 _c28076636
_d28076636